Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors

NCT06167317 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

254

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: GS-0201
DRUG: Sacituzumab Govitecan

Sponsor

Gilead Sciences